Arkolith/Insider Trading/BCAX/Form 4

Hyep Ivan

Chief Financial OfficerBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed Jul 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$808K
Net Open-Market Flow
-$808K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 8, 2026Option exercise(M)13K$3.79$47K158K
Jul 8, 2026Sell(S)23K$28.60$651K135K
Jul 8, 2026Sell(S)4K$29.82$132K131K
Jul 8, 2026Sell(S)830$30.31$25K130K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 8, 2026Option exercise(M)12K—$059K
Jul 8, 2026Option exercise(M)908—$039K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000700) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML